HSA — authorised 28 February 2001
- Marketing authorisation holder: JANSSEN PHARMS
- Status: likely_approved
HSA authorised Razadyne on 28 February 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 28 February 2001.
JANSSEN PHARMS holds the Singaporean marketing authorisation.